Non-target lesions. All non-measurable lesions (or sites of disease) plus any measurable lesions over and above the 10 listed as target lesions. Measurements are not required, but these lesions should be noted at baseline and should be followed as “present” or “absent”. All lesions that arise during the study and lesions that change from non-measurable to measurable during the study should be entered as non-target lesions.
Appears in 1 contract
Sources: Investigator Agreement
Non-target lesions. All non-measurable lesions (or sites of disease) plus any measurable lesions over and above the 10 those listed as target lesions are considered non- target lesions. Measurements are not required, required but these lesions should be noted at baseline and should be followed as “present” or “absent”. All lesions that arise during the study and lesions that change from non-measurable to measurable during the study should be entered as non-target lesions.
Appears in 1 contract
Sources: Investigator Protocol Agreement